Danes seek compromise on EU bioethics research programme
This article was originally published in Clinica
Executive Summary
The Danish presidency of the European Union has drawn up a proposed compromise deal on bioethics in an aim to ensure there are no hitches to the progress of certain potentially controversial research programmes within the EU's Sixth Framework Programme (FP6). The FP6 programme, a five-year research programme beginning in 2003, focuses on many medical-related areas, including nanotechology, where medical testing of prosthetics and drug delivery are among the sectors most likely to benefit.